McDonald’s E.coli Crisis: This Canadian Biotech May Have The Solution | Cytophage with Steven Theriault
In this interview, Dr. Steven Theriault, CEO & Chief Science Officer of Cytophage Technologies (TSXV: CYTO), discusses the company’s innovative approach to addressing bacterial infections through bacteriophage technology.
Read more